Pets Diagnostics IDEXX operates in a growing companion-animal health market with a broad diagnostic testing and software ecosystem, presenting cross-sell opportunities for in-clinic instruments, reference lab services, telemedicine, and practice management software to veterinary clients.

Global Expansion With operations in over 70 locations and customers in more than 175 countries, there is substantial opportunity to expand product adoption internationally, especially in regions where installed base for core diagnostic machines is still expanding.

AI Driven Recent investor focus on AI driven diagnostics and software offerings suggests a path to upsell advanced analytics, decision-support tools, and AI-enabled testing pipelines to increase testing utilization in veterinary practices.

Cardiac Catalyst New Catalyst proBNP dual-species test expands point-of-care cardiac assessment, signaling potential upsell to veterinarians for broader diagnostic panels and cross-selling related cartridges, services, and software integrations.

Financial Momentum Steady revenue growth, strong recurring revenue from diagnostics and software, and ongoing international expansion point to scalable upsell opportunities in practice management software, telemedicine services, and recurring consumables.